Cognex (NASDAQ:CGNX) Price Target Cut to $57.00 by Analysts at Truist Financial

Key Points

• Truist Financial cut its Cognex price target from $74 to $57 and maintained a Hold rating; the new target implies 18.63% upside from the prior close.
• Analyst views remain broadly positive: MarketBeat reported a consensus Moderate Buy rating and an average price target of $73.29, despite several firms lowering their targets.
• Cognex reported quarterly EPS of $0.53, slightly above estimates, while revenue rose 13% year over year to $313.39 million—just below expectations.

Cognex (NASDAQ:CGNX - Get Free Report) had its price target reduced by equities researchers at Truist Financial from $74.00 to $57.00 in a research report issued to clients and investors on Friday, Benzinga reports. The brokerage currently has a "hold" rating on the scientific and technical instruments company's stock. Truist Financial's price objective suggests a potential upside of 18.63% from the company's previous close.

A number of other research firms have also recently issued reports on CGNX. Needham & Company LLC reduced their target price on shares of Cognex from $80.00 to $70.00 and set a "buy" rating for the company in a research note on Friday. Robert W. Baird decreased their price objective on shares of Cognex from $78.00 to $70.00 and set a "neutral" rating for the company in a report on Wednesday, September 23rd. Citigroup reissued a "neutral" rating and set a $74.00 target price (up from $72.00) on shares of Cognex in a research report on Friday, August 7th. Cantor Fitzgerald boosted their price target on Cognex from $76.00 to $84.00 and gave the stock an "overweight" rating in a research report on Friday, August 7th. Finally, HSBC downgraded Cognex from a "buy" rating to a "hold" rating and set a $65.00 price objective on the stock. in a research note on Monday, August 10th. One equities research analyst has rated the stock with a Strong Buy rating, ten have issued a Buy rating and seven have given a Hold rating to the company's stock. According to MarketBeat, the stock presently has a consensus rating of "Moderate Buy" and an average target price of $73.29.

Cognex Stock Performance

NASDAQ:CGNX traded up $0.56 during trading hours on Friday, hitting $48.05. 1,793,497 shares of the company's stock traded hands, compared to its average volume of 2,127,663. The stock's fifty day moving average price is $59.36 and its two-hundred day moving average price is $57.99. The firm has a market cap of $8.08 billion, a P/E ratio of 33.61 and a beta of 1.49. Cognex has a twelve month low of $34.60 and a twelve month high of $72.88.

Cognex (NASDAQ:CGNX - Get Free Report) last posted its quarterly earnings results on Wednesday, November 4th. The scientific and technical instruments company reported $0.53 EPS for the quarter, topping the consensus estimate of $0.52 by $0.01. Cognex had a net margin of 21.50% and a return on equity of 16.24%. The business had revenue of $313.39 million during the quarter, compared to analysts' expectations of $313.62 million. During the same period last year, the company posted $0.33 earnings per share. The firm's quarterly revenue was up 13.0% compared to the same quarter last year. On average, equities research analysts predict that Cognex will post 1.68 earnings per share for the current year.

Institutional Inflows and Outflows

A number of large investors have recently modified their holdings of the company. BlackRock Inc. bought a new stake in shares of Cognex during the 2nd quarter worth $1,158,123,000. Pictet Asset Management Holding SA boosted its stake in shares of Cognex by 2.7% in the 3rd quarter. Pictet Asset Management Holding SA now owns 5,985,986 shares of the scientific and technical instruments company's stock valued at $363,002,000 after purchasing an additional 156,108 shares in the last quarter. Jupiter Topco LLC acquired a new stake in Cognex in the second quarter valued at approximately $161,425,000. Sumitomo Mitsui Trust Group Inc. grew its stake in shares of Cognex by 0.5% during the third quarter. Sumitomo Mitsui Trust Group Inc. now owns 2,227,288 shares of the scientific and technical instruments company's stock worth $135,085,000 after buying an additional 11,927 shares during the last quarter. Finally, Janus Henderson Group PLC increased its holdings in shares of Cognex by 81.0% during the first quarter. Janus Henderson Group PLC now owns 2,660,411 shares of the scientific and technical instruments company's stock worth $130,320,000 after buying an additional 1,190,434 shares in the last quarter. 88.12% of the stock is currently owned by institutional investors and hedge funds.

Cognex News Roundup

Here are the key news stories impacting Cognex this week:

• Positive Sentiment: Q3 adjusted EPS of $0.53 beat estimates of about $0.52, while revenue rose 13% year over year to $313.39 million. Cognex raised its 2026 revenue outlook to $1.14 billion–$1.16 billion and cited stronger logistics demand, cost discipline and margin expansion. CGNX Q3 Earnings Call Highlights Outlook and Margin Expansion
• Positive Sentiment: The planned RealSense acquisition could add growth opportunities; the company expects to close it in Q4. Cognex also raised its quarterly dividend 5.9% to $0.09 per share. Cognex forecasts 2026 revenue and targets RealSense close in Q4
• Negative Sentiment: Quarterly revenue came in just below analyst expectations, and reports noted a post-earnings share decline—suggesting the solid results and raised outlook did not fully satisfy investors. Cognex reports Q3 2026 results and stock drops
• Negative Sentiment: KeyCorp cut its price target from $80 to $65 and Needham lowered its target from $80 to $70. Both firms kept positive ratings—Overweight and Buy, respectively—but the reductions may weigh on sentiment. KeyCorp rating and price target Needham rating and price target

Cognex Company Profile

Cognex Corporation develops machine vision and industrial identification technologies that help manufacturers and businesses automate inspection, measurement, guidance, and tracking processes. Its systems use cameras, sensors, software, and artificial intelligence to analyze images and identify products, defects, components, and other objects.

The company's product portfolio includes vision systems, industrial cameras, vision sensors, barcode readers, optical character recognition tools, three-dimensional vision systems, and machine vision software.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.